The congress will bring together 200 senior and junior scientists from around the world to interact with the most well-known world experts in breast cancer research. Both international and local speakers will cover topics related to Clinical Investigations/Clinical Trials, Stem Cells in Breast Cancer Development and Malignancy, Cancer Therapeutics, Quantitative Medicine and Breast Cancer Genomics and Mouse Models of Cancer and Pathology.
HUGO’s current president, Prof Edison Liu, Executive Director of the Genome Institute of Singapore (GIS), a biomedical research institute of the Agency for Science, Technology and Research (A*STAR), said, “This congress, jointly organised by the Human Genome Organisation and the International Association of Breast Cancer Research, focuses on the intersection of Genomics , Biology, and Breast Cancer Treatment. This focus and the partnership of the two organisations show how the genomic technologies, when combined with our knowledge of breast cancer biology, are beginning to form our strategies for personalized breast cancer therapy. In Singapore, we are working directly at the nexus of these three streams of clinical and basic sciences, and technology, and we are proud to host this exciting congress. So we invite you to attend this scientific gathering in our vibrant city-state.”
